Payer Perspective News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Payer perspective. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Payer Perspective Today - Breaking & Trending Today

Future Opportunities With Interchangeable Biosimilars

A panel of experts discuss future opportunities with interchangeable biosimilars from payer and provider perspectives. ....

Jonathan Kay , Kimberlyc Chen , Maia Kayal , Ryan Haumschild , Stakeholder Summit , Interchangeable Biosimilar , Payer Perspective , Future Opportunities , Health Care Cost ,

Addressing the Increased Amount of Interchangeable Biosimilars in the Market

Experts review best practices around plan design that payers and plan sponsors should address as more interchangeable biosimilars potentially enter the market. ....

Jonathan Kay , Kimberlyc Chen , Ryan Haumschild , Maia Kayal , Interchangeable Biosimilar , Plan Design , Payer Perspective , Plan Sponsor , Biosimilar Tier ,

Interchangeable Biosimilar Automatic Substitution

Jonathan Kay, MD, and Kimberly C. Chen, DO, MSHLM, discuss clinical and financial concerns related to automatic substitution at the pharmacy for an interchangeable biosimilar from a payer perspective. ....

Kimberlyc Chen , Jonathan Kay , Ryan Haumschild , Interchangeable Biosimilar , Automatic Substitution , Payer Perspective , Reference Product , Financial Concerns , Clinical Concerns ,

Challenges Payers Face With Biosimilars

Kimberly C. Chen DO, MSHLM, and Maia Kayal, MD, MS, review the challenges related to biosimilars from the payer perspective and strategies payers may employ to help improve the uptake of biosimilars. ....

Maia Kayal , Kimberlyc Chen , Biosimilars Stakeholder Summit , Interchangeable Biosimilars , Inflammatory Diseases , Challenges With Biosimilars , Payer Perspective , Improve Biosimilar Uptake , Biosimilar Extrapolation , Reduced Approval Time , Multiple Indications , Reference Product , Fda Approval Process ,